Jazz Pharmaceuticals plc Asset Resilience Ratio

Latest as of March 2026: 8.68%

Jazz Pharmaceuticals plc asset resilience ratio. Jazz Pharmaceuticals plc (J7Z) has an Asset Resilience Ratio of 8.68% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Jazz Pharmaceuticals plc liquidity coverage in days to measure how many days the company can operate on defensive assets alone.

Liquid Assets

€1.03 Billion

≈ $1.20 Billion USD Cash + Short-term Investments

Total Assets

€11.86 Billion

≈ $13.87 Billion USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio of Jazz Pharmaceuticals plc (2016–2025)

Asset resilience ratio of Jazz Pharmaceuticals plc from 2016 to 2025. This chart shows how Jazz Pharmaceuticals plc's Asset Resilience Ratio has changed over time. Read Jazz Pharmaceuticals plc total liabilities for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Jazz Pharmaceuticals plc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see how large is Jazz Pharmaceuticals plc's balance sheet.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	€0.00	0%
Short-term Investments	€1.03 Billion	8.68%
Total Liquid Assets	€1.03 Billion	8.68%

Asset Resilience Insights

Limited Liquidity: Jazz Pharmaceuticals plc maintains only 8.68% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Jazz Pharmaceuticals plc Industry Peers by Asset Resilience Ratio

Compare Jazz Pharmaceuticals plc's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Biomarin Pharmaceutical Inc NASDAQ:BMRN	Biotechnology	0.00%
HLB Co. Ltd KQ:028300	Biotechnology	3.29%
Tubize-Fin BR:TUB	Biotechnology	2.50%
Shanghai Medicilon Inc SHG:688202	Biotechnology	6.69%
Blue Jet Healthcare Limited NSE:BLUEJET	Biotechnology	13.81%
Hangzhou Biotest Biotech Co Ltd SHG:688767	Biotechnology	0.56%
Shouyao Holdings (Beijing) Co. Ltd. A SHG:688197	Biotechnology	79.76%
Shenzhen Weiguang Biological Products Co Ltd SHE:002880	Biotechnology	5.52%

Jazz Pharmaceuticals plc Asset Resilience Ratio by Year (2016–2025)

Jazz Pharmaceuticals plc asset resilience ratio by year from 2016 to 2025. The table below shows the annual Asset Resilience Ratio data for Jazz Pharmaceuticals plc.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	9.01%	€1.05 Billion ≈ $1.23 Billion	€11.66 Billion ≈ $13.63 Billion	+4.18pp
2024-12-31	4.83%	€580.00 Million ≈ $678.08 Million	€12.01 Billion ≈ $14.04 Billion	+3.78pp
2023-12-31	1.05%	€120.00 Million ≈ $140.29 Million	€11.39 Billion ≈ $13.32 Billion	--
2022-12-31	0.00%	€0.00 ≈ $0.00	€10.84 Billion ≈ $12.67 Billion	--
2021-12-31	0.00%	€0.00 ≈ $0.00	€12.30 Billion ≈ $14.38 Billion	--
2020-12-31	16.45%	€1.07 Billion ≈ $1.26 Billion	€6.54 Billion ≈ $7.64 Billion	+8.50pp
2019-12-31	7.94%	€440.00 Million ≈ $514.41 Million	€5.54 Billion ≈ $6.48 Billion	-1.95pp
2018-12-31	9.90%	€515.00 Million ≈ $602.09 Million	€5.20 Billion ≈ $6.08 Billion	+5.70pp
2017-12-31	4.20%	€215.00 Million ≈ $251.36 Million	€5.12 Billion ≈ $5.99 Billion	+2.95pp
2016-12-31	1.25%	€60.00 Million ≈ $70.15 Million	€4.80 Billion ≈ $5.61 Billion	--

pp = percentage points

About Jazz Pharmaceuticals plc

F:J7Z Germany Biotechnology

Market Cap

$14.15 Billion

€12.10 Billion EUR

Market Cap Rank

#1892 Global

#408 in Germany

Share Price

€192.90

Change (1 day)

+3.88%

52-Week Range

€112.70 - €225.90

All Time High

€225.90